105 related articles for article (PubMed ID: 1534181)
1. Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Nicholson RI; Kéri G
Tumour Biol; 1992; 13(1-2):44-50. PubMed ID: 1534181
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
[TBL] [Abstract][Full Text] [Related]
3. Novel antitumor peptide hormones and their effect on signal transduction.
Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Kéri G; Balogh A; Szöke B; Teplán I; Csuka O
Tumour Biol; 1991; 12(2):61-7. PubMed ID: 1902971
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICI 118630.
Nicholson RI; Walker KJ; Maynard PV
Eur J Cancer (1965); 1980; Suppl 1():295-9. PubMed ID: 6459236
[No Abstract] [Full Text] [Related]
6. Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer.
Furr BJ; Nicholson RI
J Reprod Fertil; 1982 Mar; 64(2):529-39. PubMed ID: 6461763
[No Abstract] [Full Text] [Related]
7. Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations.
Stoeckemann K; Sandow J
J Cancer Res Clin Oncol; 1993; 119(8):457-62. PubMed ID: 8509436
[TBL] [Abstract][Full Text] [Related]
8. Endocrine-dependent rat mammary tumor regression: use of a gonadotropin releasing hormone analog.
Johnson ES; Seely JH; White WF; DeSombre ER
Science; 1976 Oct; 194(4262):329-30. PubMed ID: 823643
[TBL] [Abstract][Full Text] [Related]
9. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone analogs inhibit primate granulosa cell steroidogenesis via a mechanism distinct from that in the rat.
Wickings EJ; Eidne KA; Dixson AF; Hillier SG
Biol Reprod; 1990 Aug; 43(2):305-11. PubMed ID: 2165826
[TBL] [Abstract][Full Text] [Related]
11. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
[TBL] [Abstract][Full Text] [Related]
12. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog.
Matsuzawa A; Yamamoto T
Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279
[TBL] [Abstract][Full Text] [Related]
13. Active immunization to luteinizing hormone releasing hormone to inhibit the induction of mammary tumors in the rat.
Ravdin PM; Jordan VC
Life Sci; 1988; 43(2):117-23. PubMed ID: 3134587
[TBL] [Abstract][Full Text] [Related]
14. Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo.
Maruuchi T; Sugiyama T; Kataoka A; Nishida T; Yakushiji M
Jpn J Cancer Res; 1998 Sep; 89(9):977-83. PubMed ID: 9818035
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
Yuri T; Lai YC; Yoshizawa K; Tsubura A
In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
[TBL] [Abstract][Full Text] [Related]
16. Ovarian function suppression with a GnRH analogue: D-ser(But[t])[6]-Arzgly[10]-LHRH (Goserelin) in hormone dependent canine mammary cancer.
Lombardi P; Florio S; Pagnini U; Crispino A; Avallone L
J Vet Pharmacol Ther; 1999 Feb; 22(1):56-61. PubMed ID: 10211718
[TBL] [Abstract][Full Text] [Related]
17. Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on 7, 12- dimethylbenz (a)anthracene-induced rat mammary tumors. Histological and endocrine studies.
Danguy A; Legros N; Heuson-Stiennon JA; Pasteels JL; Atassi G; Heuson JC
Eur J Cancer (1965); 1977 Oct; 13(10):1089-94. PubMed ID: 411660
[No Abstract] [Full Text] [Related]
18. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats.
Yoshida H; Fukunishi R; Kato Y; Matsumoto K
J Natl Cancer Inst; 1980 Oct; 65(4):823-8. PubMed ID: 6775121
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
[TBL] [Abstract][Full Text] [Related]
20. Active immunization of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
Esbenshade KL; Britt JH
Biol Reprod; 1985 Oct; 33(3):569-77. PubMed ID: 2932169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
